Anxiety and depression are prevalent in patients with IPF and are linked to increased breathlessness and lower energy levels.
Sleep Apnea Solution author Dylan Petkus, MD, has developed a non-device, behavior-based alternative approach to sleep apnea.
The Food and Drug Administration (FDA) has approved Breztri Aerosphere ® (budesonide/glycopyrrolate/formoterol fumarate; BGF) for the maintenance treatment of asthma in adult and ...
The FDA is moving to speed drug development and review by launching real-time clinical trials, which could mean more options for patients.
The FDA has accepted the NDA for zipalertinib to treat adult patients with locally advanced or metastatic EGFR exon 20 insertion-mutated NSCLC.
In cystic fibrosis, ETI significantly reduced daily cough frequency and increased physical activity levels in patients aged 12 and older.
Cannabis use may impact glycemic control by impairing self-management behaviors and delaying gastric emptying among patients ...
The updated guideline also strongly recommends RSV vaccination in adults and adolescents with compromised immunity. RSV ...
Oncologists are leveraging TikTok to provide evidence-based cancer education, breaking down complex clinical topics for ...
CFTR modulators, especially triple therapy, significantly improve sinonasal inflammation and nasal polyp size in patients with cystic fibrosis.
Young patients with lung cancer have significantly higher fruit, vegetable, and whole grain consumption than the US reference ...
Patients with interstitial lung disease who are positive for anti-Ku antibody may show progressive fibrotic behavior.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results